[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-342155-105":59,"doc-detail-342155-en":134},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":127,"head_meta":129,"extra_data":131,"updated_unix":133},105,"en","exposure-to-brominated-flame-retardants-in-utero-and-through-lactation-delays-the-development-of-dmba-induced-mammary-cancer-potential-effects-on-subtypes","Exposure to brominated flame retardants in utero and through lactation delays the development of DMBA-induced mammary cancer - potential effects on subtypes?","","Brominated flame retardants (BFRs) are used to reduce product flammability, and some act as endocrine-disrupting chemicals that can leach into the environment, creating human and wildlife exposure. The mammary gland is vulnerable during in utero life, puberty, and pregnancy. This study assessed whether gestational and lactational BFR exposure increases susceptibility to 7,12-dimethylbenz[a]anthracene (DMBA)-induced mammary cancer, evaluating tumor timing, growth, histology, and molecular subtype patterns.",{"@graph":69,"@context":126},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/exposure-to-brominated-flame-retardants-in-utero-and-through-lactation-delays-the-development-of-dmba-induced-mammary-cancer-potential-effects-on-subtypes/342155/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/exposure-to-brominated-flame-retardants-in-utero-and-through-lactation-delays-the-development-of-dmba-induced-mammary-cancer-potential-effects-on-subtypes/342155.png","ImageObject",300,407,{"name":92,"@type":93},"Evangeline","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-16","2026-09-22",true,{"@type":102,"interactionType":103,"userInteractionCount":52},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118,122],{"name":109,"@type":110,"acceptedAnswer":111},"What is the study’s main objective?","Question",{"text":112,"@type":113},"To determine whether in utero and lactational exposure to brominated flame retardants makes the mammary gland more susceptible to DMBA-induced mammary cancer.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How were tumors induced and monitored in the experimental design?",{"text":117,"@type":113},"Dams were exposed to a BFR mixture, and pups received DMBA at post-natal day 46. Tumor onset and growth were monitored, and tumors were characterized using histology and molecular biology.",{"name":119,"@type":110,"acceptedAnswer":120},"Did BFR exposure change how many tumors developed?",{"text":121,"@type":113},"BFR exposure did not significantly affect mammary tumor number or burden, but it delayed tumor onset and growth in exposed animals.",{"name":123,"@type":110,"acceptedAnswer":124},"What molecular changes were observed in tumors from BFR-exposed animals?",{"text":125,"@type":113},"Molecular analysis showed a shift in the ratio of luminal A, luminal B, and (HER2)-enriched tumors, along with an increase in triple-negative breast cancer (TNBC) subtypes.","https://schema.org",{"og:url":83,"og:type":128,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":130,"canonical":83},"index,follow",{"doc_id":132,"site_id":62},342155,1790179692,{"code":4,"msg":5,"data":135},{"doc_id":132,"user_id":136,"nickname":92,"user_avatar":137,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":138,"file_id":139,"file_url":140,"file_type":141,"file_size":142,"view_count":52,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":143,"language":144,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":145,"faqs":146,"seo_title":147,"seo_description":67,"update_tm":148,"read_time":36,"preview_page_count":19,"preview_urls":149},13056703019662,"https://ap-avatar.wpscdn.com/avatar/be000253a8e92610077?_k=1778726343310543188","TYPE Original Research PUBLISHED 14 November 2024 DOI 10.3389/fendo.2024.1429142  \nOPEN ACCESS  \nEDITED BY  \nAna Paula Santos-Silva,  \nFederal University of Rio de Janeiro, Brazil  \nREVIEWED BY  \nPaula Rodrigues Pereira,  \nFederal University of Rio de Janeiro, Brazil D’Angelo Magliano,  \nFluminense Federal University, Brazil Sulev Kõks,  \nMurdoch University, Australia Taisen Iguchi,  \nGraduate University for Advanced Studies (Sokendai), Japan  \n*CORRESPONDENCE  \nIsabelle Plante  \n [isabelle.plante@inrs.ca](isabelle.plante@inrs.ca)  \nRECEIVED 07 May 2024  \nACCEPTED 21 October 2024  \nPUBLISHED 14 November 2024  \nCITATION  \nJuarez MN, McDermott A, Wade MG and Plante I (2024) Exposure to brominated ﬂame retardants in utero and through lactation delays the development of DMBA-induced mammary cancer:  \npotential effects on subtypes?  \nFront. Endocrinol. 15:1429142 .  \ndoi: 10.3389/fendo.2024.1429142  \nCOPYRIGHT  \n© 2024 Juarez, McDermott, Wade and Plante. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY) . The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.  \nExposure to brominated ﬂame retardants in utero and through lactation delays the development of DMBA-induced mammary cancer: potential effects on subtypes?  \nMelany N. Juarez 1, Alec McDermott 1, Michael G. Wade 2 and Isabelle Plante 1*  \n1 INRS-Centre Armand-Frappier Sante´ Biotechnologie, Laval, QC, Canada, 2 Environmental Health Science and Research Bureau, Healthy Environments and Consumer Safety Branch, Health Canada, Ottawa, ON, Canada  \nIntroduction: Brominated ﬂame retardants (BFRs) are chemical compounds used to reduce the ﬂammability of various products; some BFRs exhibit endocrine-disrupting properties and can leach into the environment leading to human and wildlife exposure. The mammary gland has speciﬁc vulnerability windows during which it is more sensitive to the effects of endocrine disrupting compounds (EDCs), such as the in utero life, puberty and pregnancy. Our previous studies revealed precocious mammary gland development, disruptions in junctional proteins, and altered proliferation-apoptosis balance during puberty in rats exposed to BFRs in utero and through lactation. Such effects have been associated with increased mammary cancer risk.  \nObjective: The current study aimed to determine if in utero and lactational exposure to BFRs renders the mammary gland more susceptible to 7,12-dimethylbenz[a]anthracene (DMBA)-induced mammary cancer.  \nMethods: Dams were exposed to a BFRs mixture (0 . 0. 06 or 60 mg/kg/day), and mammary cancer was induced in pups using DMBA at post-natal day 46 . Tumors onset and growth were monitored, and tumors were characterized using histology and molecular biology.  \nResults: Although BFRs exposure did not signiﬁcantly affect mammary tumor number or burden, it showed signiﬁcant delay in mammary tumor onset and growth in BFR-exposed animal. These effects could potentially be due to BFRs’impact on cellular responses, DMBA metabolism, or mammary gland shift of the sensitivity window. Molecular analysis of mammary tumors showed a shift in the ratio of luminal A, luminal B, and (HER2)-enriched tumors, and an increase in triple-negative breast cancer (TNBC) subtypes in BFR-exposed animals. Additionally, BFRs exposure showed lung lesions indicative of inﬂammation, independent of mammary cancer development.  \nFrontiers in Endocrinology 01 [frontiersin.org](frontiersin.org)  \nConclusion: Our study highlights the complex relationship between BFRs exposure and mammary cancer risk, emphasizing the need for further investigation into underlying mechanisms and long-term effects of BFRs on mammary gland dev","cbCaisjusHc71XZL","https://ap.wps.com/l/cbCaisjusHc71XZL","pdf",6048318,16,"English","# Introduction\n## Brominated flame retardants and exposure pathways\n## Mammary gland vulnerability windows\n# Objective\n# Methods\n## Animal exposure and DMBA induction\n## Tumor monitoring and characterization\n# Results\n## Tumor onset and growth effects\n## Molecular subtype shifts\n## Lung inflammatory lesions\n# Conclusion","[{\"question\":\"What is the study’s main objective?\",\"answer\":\"To determine whether in utero and lactational exposure to brominated flame retardants makes the mammary gland more susceptible to DMBA-induced mammary cancer.\"},{\"question\":\"How were tumors induced and monitored in the experimental design?\",\"answer\":\"Dams were exposed to a BFR mixture, and pups received DMBA at post-natal day 46. Tumor onset and growth were monitored, and tumors were characterized using histology and molecular biology.\"},{\"question\":\"Did BFR exposure change how many tumors developed?\",\"answer\":\"BFR exposure did not significantly affect mammary tumor number or burden, but it delayed tumor onset and growth in exposed animals.\"},{\"question\":\"What molecular changes were observed in tumors from BFR-exposed animals?\",\"answer\":\"Molecular analysis showed a shift in the ratio of luminal A, luminal B, and (HER2)-enriched tumors, along with an increase in triple-negative breast cancer (TNBC) subtypes.\"}]","Exposure to brominated flame retardants in utero and through lactation delays the development of DMBA-induced mammary cancer - potential effects on subtypes? | PDF",1790045551,[150,154,158,162],{"page_no":8,"url":151,"width":152,"height":153},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/d88ea2e5553e9802cad8e4f124bf7441.webp",983,1389,{"page_no":14,"url":155,"width":156,"height":157},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/8bcfa968ad4d59667d9fd006451e27e3.webp",982,1388,{"page_no":81,"url":159,"width":160,"height":161},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/667958c282aa8280dec79b3e93af6aba.webp",981,1386,{"page_no":19,"url":163,"width":164,"height":165},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/b373b82aa0c6ac44855ab375ec8c64a9.webp",980,1385]